// App-Quantinova.ai

TPS9108 : Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): A prospective German registry in stage IV NSCLC AIO-TRK-0315.

Researchers

Presenter

  • Frank Griesinger

Principal Investigators

  • Wilfried Ernst Erich Eberhardt

  • Norbert Marschner

  • Martina Janicke

  • Lisa Spring

  • Joerg Sahlmann

  • Aysun Karatas

  • Annette Hipper

  • Martin Sebastian

  • Michael Thomas

Medical Centers

  • Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany

  • Department of Medical Oncology, University Hospital Essen, West German Cancer Centre, Ruhrlandklinik, and University Duisburg-Essen, Essen, Germany

  • Praxis fur interdisziplinare Onkologie und Hamatologie, Freiburg, Germany

  • iOMEDICO, Freiburg, Germany

  • AIO-Studien-gGmbH, Berlin, Germany

  • AIO-Studien-gGmbH, Berlin, Germany

  • Medizinische Klinik II Hamatologie/Onkologie, Rheumatologie, Infektiologie, HIV Klinikum der J.W. Goethe-Universitat Frankfurt, Frankfurt Am Main, Germany

  • Thoraxklinik am Universitatsklinikum Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany

Locations

  • Germany

Companies

  • AIO-Studien-gGmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Depression

  • Solid malignancies

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT02622581

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved